Maider Medical Industry Equipment Co. Ltd. (SHA:688310)

SHA:688310 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	276.34	271.28	476.26	380.08	313.06	262.83
Other Revenue	3.58	3.58	3.96	3.41	2.46	0.34
Revenue	279.92	274.85	480.22	383.49	315.53	263.17
Revenue Growth (YoY)	-24.32%	-42.77%	25.22%	21.54%	19.89%	25.59%
Cost of Revenue	174.67	156.93	235.72	191.43	159.32	131.45
Gross Profit	105.25	117.92	244.5	192.06	156.21	131.72
Selling, General & Admin	108.53	120.26	118.01	93.77	64.56	48.73
Research & Development	42.67	40.41	33.18	36.66	38.46	26.23
Other Operating Expenses	-8.59	-9.6	-16.01	-9.02	-5.89	-7.38
Operating Expenses	138.59	147.4	138.76	125.65	99.2	74.36
Operating Income	-33.33	-29.48	105.74	66.41	57.01	57.36
Interest Expense	-1.13	-0.06	-0.08	-0.1	-0.12	-0.15
Interest & Investment Income	1.87	3.09	7.26	13.61	7.33	12.9
Currency Exchange Gain (Loss)	-0.33	-0.33	0.53	0.68	-0.71	0.15
Other Non Operating Income (Expenses)	1.28	-0.12	-0.08	-0.06	-0.07	1.23
EBT Excluding Unusual Items	-31.65	-26.9	113.37	80.54	63.45	71.5
Impairment of Goodwill	-10.42	-10.42	-	-	-	-
Gain (Loss) on Sale of Investments	2.42	2.24	2.66	0.15	0.03	-0.13
Gain (Loss) on Sale of Assets	-0.3	0.3	-0.03	0.21	-0.06	-0.01
Asset Writedown	-0.49	-	-	-	-	-1.79
Legal Settlements	-	-	-	-	-	-0.94
Other Unusual Items	7.36	5.55	11.43	6.33	7.05	-
Pretax Income	-33.08	-29.23	127.43	87.22	70.47	68.63
Income Tax Expense	4.42	0.78	17.82	10.2	6.5	10.46
Earnings From Continuing Operations	-37.51	-30.01	109.61	77.02	63.97	58.17
Minority Interest in Earnings	18.73	10.03	-9.78	-10	0.51	0.9
Net Income	-18.77	-19.98	99.83	67.02	64.48	59.07
Net Income to Common	-18.77	-19.98	99.83	67.02	64.48	59.07
Net Income Growth	-	-	48.94%	3.95%	9.15%	26.35%
Shares Outstanding (Basic)	185	167	164	165	164	163
Shares Outstanding (Diluted)	185	167	164	165	164	163
Shares Change (YoY)	19.44%	1.75%	-0.60%	0.32%	0.63%	29.91%
EPS (Basic)	-0.10	-0.12	0.61	0.41	0.39	0.36
EPS (Diluted)	-0.10	-0.12	0.61	0.41	0.39	0.36
EPS Growth	-	-	49.84%	3.61%	8.48%	-2.74%
Free Cash Flow	70.72	-29.46	38.7	-38.36	-27.77	3.91
Free Cash Flow Per Share	0.38	-0.18	0.24	-0.23	-0.17	0.02
Dividend Per Share	-	-	0.357	0.245	0.194	0.255
Dividend Growth	-	-	45.81%	26.30%	-23.99%	42.83%
Gross Margin	37.60%	42.90%	50.91%	50.08%	49.51%	50.05%
Operating Margin	-11.91%	-10.73%	22.02%	17.32%	18.07%	21.80%
Profit Margin	-6.71%	-7.27%	20.79%	17.48%	20.43%	22.45%
Free Cash Flow Margin	25.26%	-10.72%	8.06%	-10.00%	-8.80%	1.49%
EBITDA	-0.76	1.32	134.17	81.44	63.48	63.53
EBITDA Margin	-0.27%	0.48%	27.94%	21.24%	20.12%	24.14%
D&A For EBITDA	32.57	30.8	28.43	15.03	6.47	6.17
EBIT	-33.33	-29.48	105.74	66.41	57.01	57.36
EBIT Margin	-11.91%	-10.73%	22.02%	17.32%	18.07%	21.80%
Effective Tax Rate	-	-	13.99%	11.69%	9.23%	15.24%
Revenue as Reported	279.92	274.85	480.22	383.49	315.53	263.17
Advertising Expenses	-	3.87	5.34	0.91	0.9	1.28

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.